EN DE
STOCK COMPARISON

Neousys Technology vs Corticeira Amorim: Fair Value & Quality

Both stocks run through our valuation models. Here is how Neousys Technology (6922) and Corticeira Amorim (COR) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Corticeira Amorim as the more attractively valued of the two: Neousys Technology trades at TWD 204 versus a fair value of TWD 173 (-15%), while Corticeira Amorim trades at €6.61 versus €8.24 (+25%).
Neousys Technology
6922.TWO · TWD · Health Care
-15%
upside to fair value
overvalued
PriceTWD 204
Fair ValueTWD 173
Quality46/100
Corticeira Amorim
COR.LS · EUR · Materials
+25%
upside to fair value
undervalued
Price€6.61
Fair Value€8.24
Quality68/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Neousys TechnologyCorticeira Amorim
Valuation
28.6×P/E (TTM)16.1×
3.04×P/S (TTM)1.21×
5.04×P/B1.35×
19.4×EV/EBITDA7.9×
PEG0.51×
2.5%Dividend yield5.3%
TWD 4.83Dividend per share€0.35
Profitability
11%Net margin6%
18%Operating margin10%
20%Return on equity7%
8%Return on assets4%
Growth
22%Revenue growth (YoY)-8%
8.6%Avg. growth/yr (3Y)-5.5%
Avg. growth/yr (5Y)3.1%
Balance & size
0.54×Debt / equity0.13×
$164MMarket cap$1B
expensiveGrowth qualitymixed

Even match: 6 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Neousys Technologyof which business quality 46 · market factors 62 Corticeira Amorimof which business quality 69 · market factors 56
ProfitabilityMargins and returns on capital today
60
46
Quality GrowthAre margins and returns improving?
48
53
CashflowEarnings quality: real cash, not paper profit
8
79
Fin. StrengthBalance sheet, leverage, solvency risk
81
72
InvestmentDisciplined investing over empire-building
15
88
Low VolatilityCalm price path (market factor)
64
96
MomentumPrice trend over the last 3–12 months (market factor)
62
43
52W MomentumDistance to the 52-week high (market factor)
62
32
Net IssuanceBuybacks instead of dilution
53
82

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Neousys Technology

Earnings-BasedTWD 101
Dividend DiscountTWD 74.18
MultiplesTWD 129
Asset-BasedTWD 25.84
Economic ProfitTWD 75.91
Growth EarningsTWD 151

15 of 16 models see the stock below the current price.

Corticeira Amorim

DCF Models€10.29
Earnings-Based€4.18
Multiples€7.47
Asset-Based€3.78
Growth DCF€12.09
Economic Profit€4.67
Growth Earnings€5.42

7 of 22 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Neousys Technology
Bear TWD 121Fair Value TWD 173Bull TWD 225
TWD 204 = current price (white tick)
Corticeira Amorim
Bear €6.18Fair Value €8.24Bull €10.30
€6.61 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Neousys Technology · Health Care

Quality score46 · below median
Fair value upside-15% · above median

Corticeira Amorim · Materials

Quality score68 · Top 25%
Fair value upside+25% · Top 25%

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Corticeira Amorim as the more attractively valued of the two: Neousys Technology trades at TWD 204 versus a fair value of TWD 173 (-15%), while Corticeira Amorim trades at €6.61 versus €8.24 (+25%).

Corticeira Amorim has the higher quality score (68/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.